151 related articles for article (PubMed ID: 32478495)
21. Evaluation of the clinical significance of long non-coding RNA
Lin SH; Lu JW; Hsieh WT; Chou YE; Su TC; Tsai TJ; Tsai YJ; Yang PJ; Yang SF
Aging (Albany NY); 2024 Mar; 16(6):5740-5750. PubMed ID: 38517388
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic implications of lncRNA NORAD in breast cancer.
Zhang Y; Fan X; Hong J; Yang E; Xuan C; Fang H; Ding X
Sci Rep; 2023 Nov; 13(1):20426. PubMed ID: 37993524
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effects of miR-143 with miR-99a inhibited cell proliferation and induced apoptosis in breast cancer.
Doosti Z; Ebrahimi SO; Ghahfarokhi MS; Reiisi S
Biotechnol Appl Biochem; 2024 Apr; ():. PubMed ID: 38689536
[TBL] [Abstract][Full Text] [Related]
24. Genomic instability-associated two-miRNA signature as a novel prognostic biomarker in breast cancer.
Zhang Y; Chen Y; Liu T
J Gene Med; 2024 Jan; 26(1):e3604. PubMed ID: 37880853
[TBL] [Abstract][Full Text] [Related]
25. EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.
Chekhun V; Borikun T; Mushii O; Zadvornyi T; Martyniuk О; Kashuba E; Bazas V; Hrybach S; Krotevych M; Lyalkin S; Lukianova N
Exp Oncol; 2024 Feb; 45(4):421-431. PubMed ID: 38328848
[TBL] [Abstract][Full Text] [Related]
26. ABERRANT EXPRESSION OF COL14A1, CELRS3, and CTHRC1 IN BREAST CANCER СELLS.
Malvia S; Chintamani C; Sarin R; Dubey US; Saxena S; Bagadi SAR
Exp Oncol; 2023 Jun; 45(1):28-43. PubMed ID: 37417284
[TBL] [Abstract][Full Text] [Related]
27. Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients.
Escuin D; López-Vilaró L; Bell O; Mora J; García-Valdecasas B; Moral A; Clos M; Boronat L; Arqueros C; Barnadas A
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686099
[TBL] [Abstract][Full Text] [Related]
28. Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis.
Sun YL; Zhao YX; Guan YN; You X; Zhang Y; Zhang M; Wu HY; Zhang WJ; Yao YZ
Adv Ther; 2023 Sep; 40(9):4004-4023. PubMed ID: 37422893
[TBL] [Abstract][Full Text] [Related]
29. Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer.
Miao S; Ju G; Jiang C; Xue B; Zhao L; Zhang R; Diao H; Yu X; Zhang L; Pan X; Zhang H; Zang L; Wang L; Zhou T
Front Med (Lausanne); 2023; 10():1167676. PubMed ID: 37081842
[TBL] [Abstract][Full Text] [Related]
30. Identification of Neck Lymph Node Metastasis-Specific microRNA-Implication for Use in Monitoring or Prediction of Neck Lymph Node Metastasis.
Higashi Y; Nakamura K; Takaoka R; Tani M; Noma Y; Mori K; Yamashiro K; Yokoyama S; Hamada T; Sugiura T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568586
[TBL] [Abstract][Full Text] [Related]
31. A novel long non-coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer.
Sun X; Li W; Li G; Yang H; Jiang Z; Shen L; Shen Y; Liu Y; Wang G
J Cell Mol Med; 2024 Apr; 28(8):e18275. PubMed ID: 38568058
[TBL] [Abstract][Full Text] [Related]
32. ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer.
Shen J; Ma H; Chen Y; Shen J
Oncol Res; 2023; 31(6):955-966. PubMed ID: 37744272
[TBL] [Abstract][Full Text] [Related]
33. The relationship between tissue differentiation-inducing non-protein coding RNA expression and tumor size in patients with breast cancer.
Tan S; Cui A; Bai N; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):104-108. PubMed ID: 37715415
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of the prognostic characteristics of microRNAs in breast cancer.
Wang L; Wang G; Song J; Yao D; Wang Y; Chen T
Front Genet; 2024; 15():1293824. PubMed ID: 38572416
[TBL] [Abstract][Full Text] [Related]
35. The role of miRNAs as biomarkers in breast cancer.
Baylie T; Kasaw M; Getinet M; Getie G; Jemal M; Nigatu A; Ahmed H; Bogale M
Front Oncol; 2024; 14():1374821. PubMed ID: 38812786
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the regulation of metastasis-associated lung adenocarcinoma transcript 1 on the biological behavior of breast cancer.
He X; Miao Q; Yi Y; Hu W; Wu M; Wu Y; Zhang Q
Transl Cancer Res; 2021 Apr; 10(4):1609-1619. PubMed ID: 35116487
[TBL] [Abstract][Full Text] [Related]
37. Survival advantage and clinicopathological significance of microRNA-22 in cancers: a meta-analysis.
Xiang Q; Xiang Z; Dou R; Xiong B
Cancer Manag Res; 2019; 11():8855-8868. PubMed ID: 31632145
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features associated to MiRNA-195 expression in patients with breast cancer: Evidence of a potential biomarker.
Nadeem F; Hanif M; Ahmed A; Jamal Q; Khan A
Pak J Med Sci; 2017; 33(5):1242-1247. PubMed ID: 29142572
[TBL] [Abstract][Full Text] [Related]
39. BPIFB1 promotes metastasis of hormone receptor-positive breast cancer via inducing macrophage M2-like polarization.
Hu A; Liu Y; Zhang H; Wang T; Zhang J; Cheng W; Yu T; Duan Y; Feng J; Chen Z; Ding Y; Li Y; Li M; Rong Z; Shang Y; Shakila SS; Zou Y; Ma F; Guo B
Cancer Sci; 2023 Nov; 114(11):4157-4171. PubMed ID: 37702269
[TBL] [Abstract][Full Text] [Related]
40. Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients.
Motamedi M; Hashemzadeh Chaleshtori M; Ghasemi S; Mokarian F
Breast Cancer (Dove Med Press); 2019; 11():293-301. PubMed ID: 31749630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
